PTEN is a commonly altered tumor suppressor gene in human lung cancers [8], and immunohistochemical analysis demostrated that PTEN levels are reduced in 70 and 77% of patients with SCC and AD hystologies, respectively [9]. This evidence concerns the gene PTEN and lung cancer.